{"id":"W2899995714","doi":"10.1093/neuonc/noy148.039","title":"ACTR-02. NRG ONCOLOGY/RTOG 0424: LONG-TERM RESULTS OF A PHASE II STUDY OF TEMOZOLOMIDE-BASED CHEMORADIOTHERAPY REGIMEN FOR HIGH-RISK LOW-GRADE GLIOMAS","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"Cancer Care Ontario","funders":"","keywords":"Temozolomide; Medicine; Internal medicine; Oncology; Chemoradiotherapy; Hazard ratio; Regimen; Population; Glioma; Clinical endpoint; Radiation therapy; Phases of clinical research; Chemotherapy; Confidence interval; Clinical trial","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006672163,0.0004698823,0.001861095,0.0005154273,0.000201064,0.00000918186,0.0003452697,0.0004463643,0.00009133554],"category_scores_gemma":[0.0006006086,0.0003875253,0.0002960862,0.0005589784,0.0005288103,0.00007133173,0.00009875886,0.0003138807,0.00001181513],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004891119,"about_ca_system_score_gemma":0.0007003964,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002871286,"about_ca_topic_score_gemma":0.0004586144,"domain_scores_codex":[0.9963058,0.000460077,0.001273036,0.0009210659,0.0004061385,0.0006338686],"domain_scores_gemma":[0.9951039,0.001667859,0.001301559,0.001135106,0.0004892086,0.0003023471],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.04085943,0.07960436,0.03070376,0.0002014532,0.001245618,0.001352751,0.003329414,0.00001235895,0.743322,0.00004809971,0.01088277,0.08843795],"study_design_scores_gemma":[0.1564836,0.210384,0.01658882,0.00009034807,0.001238539,0.0001037493,0.0002247717,0.0001418684,0.6051129,0.00004543873,0.009314826,0.0002711307],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.99056,0.0002246694,0.00004485474,0.003893639,0.000736094,0.003934786,0.0002242849,0.0000911309,0.0002905446],"genre_scores_gemma":[0.9966953,0.0001123953,0.0009901989,0.0008797934,0.0005316638,0.0005620263,0.0001065254,0.00008856447,0.0000335529],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1382091,"threshold_uncertainty_score":0.9998577,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03064476972421659,"score_gpt":0.3551973150370242,"score_spread":0.3245525453128076,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}